About 31% of children and adolescents with Raynaud’s phenomenon have vitamin D deficiency, and according to Gram Research analysis of this single-center study, those with low vitamin D experienced more severe symptoms. When vitamin D-deficient patients received supplements, their symptom severity scores decreased significantly during follow-up. While this exploratory research suggests vitamin D screening and supplementation may help children with severe Raynaud’s, larger randomized trials are needed to confirm these findings.
Researchers studied 61 children and teens with Raynaud’s phenomenon, a condition where fingers turn white or blue in the cold. According to Gram Research analysis, about one-third of these young patients had vitamin D deficiency. The study found that kids with low vitamin D had more severe symptoms, and when they took vitamin D supplements, their symptoms improved. This exploratory research suggests doctors should check vitamin D levels in children with severe Raynaud’s, though larger studies are needed to confirm these findings.
Key Statistics
A single-center retrospective study of 61 children and adolescents with Raynaud’s phenomenon found that 31.1% had vitamin D deficiency, with vitamin D-deficient patients showing significantly higher baseline symptom severity scores compared to those with normal vitamin D levels.
Among vitamin D-deficient children and adolescents with Raynaud’s phenomenon, those who received cholecalciferol supplementation showed significant decreases in their Raynaud’s Condition Score during follow-up periods averaging 3 years, according to a 2026 study of 61 pediatric patients.
A 2026 exploratory study of 61 children with Raynaud’s phenomenon found that vitamin D deficiency was significantly associated with longer disease duration, higher baseline symptom severity, and lower quality of life scores compared to vitamin D-sufficient patients.
The Quick Take
- What they studied: Whether children and teens with Raynaud’s phenomenon (a condition where fingers turn white or blue in cold weather) have low vitamin D levels, and whether vitamin D supplements help reduce symptoms.
- Who participated: 61 children and adolescents with Raynaud’s phenomenon who visited a pediatric rheumatology clinic between 2010 and 2025. They were followed for an average of 3 years.
- Key finding: About 31% of the young patients had vitamin D deficiency. Those with low vitamin D had more severe symptoms at the start of the study. When vitamin D-deficient patients received supplements, their symptom severity scores decreased significantly during follow-up.
- What it means for you: If your child has Raynaud’s phenomenon, especially if symptoms are severe, asking a doctor to check vitamin D levels may be worthwhile. Vitamin D supplements might help reduce symptom severity, though more research is needed before this becomes standard treatment.
The Research Details
This was a retrospective observational study, meaning researchers looked back at medical records of children and teens who had already been treated at a pediatric rheumatology clinic. They collected information about 61 patients seen between 2010 and 2025, examining their vitamin D levels, symptom severity, and other blood test results at the start of the study. Patients were then followed over time (averaging 3 years) to see how their symptoms changed, especially those who received vitamin D supplements. The researchers used a standardized scoring system called the Raynaud’s Condition Score to measure symptom severity every two weeks. They also performed a special imaging test called nailfold videocapillaroscopy to examine tiny blood vessels in the fingernails.
This research approach is important because it allowed researchers to identify a potential connection between vitamin D deficiency and Raynaud’s severity in real-world clinical practice. By following patients over years, they could observe whether vitamin D supplementation actually improved symptoms. This type of exploratory study helps identify patterns that warrant larger, more rigorous trials. The study’s strength lies in its detailed clinical data collection and long follow-up period, which provides real-world evidence about how vitamin D affects children with this condition.
This study has some important limitations to understand. It was conducted at a single medical center, so results may not apply to all children everywhere. The sample size of 61 patients is relatively small for drawing firm conclusions. This was an observational study, not a randomized controlled trial, meaning researchers couldn’t control all variables that might affect outcomes. The study is exploratory in nature, meaning it’s designed to identify patterns for future research rather than prove cause-and-effect. The authors themselves recommend that larger, prospective randomized controlled trials are needed to confirm these findings.
What the Results Show
The study found that 19 out of 61 children and adolescents (31.1%) had vitamin D deficiency. This is a notable finding because vitamin D deficiency was significantly more common in patients with more severe Raynaud’s symptoms. When researchers compared vitamin D-deficient patients to those with normal vitamin D levels, they found important differences: vitamin D-deficient patients had longer disease duration, higher baseline symptom severity scores, and lower quality of life ratings. After adjusting for age and sex, the connection between vitamin D deficiency and symptom severity remained statistically significant. Most importantly, among the vitamin D-deficient patients who received cholecalciferol (vitamin D) supplements, the Raynaud’s Condition Score decreased significantly during the follow-up period, suggesting that correcting the deficiency may improve symptoms.
Other laboratory tests including inflammatory markers, complement proteins, liver function, kidney function, lipid profiles, and autoimmune panels did not show significant differences between groups. However, the study did find that lupus-like anticoagulant positivity was more common in vitamin D-deficient patients, which is interesting because it suggests a possible connection between vitamin D status and blood clotting factors. Quality of life measures, assessed using a visual analog scale, were significantly lower in vitamin D-deficient patients at baseline.
This is one of the first studies to specifically examine the relationship between vitamin D deficiency and Raynaud’s phenomenon in children and adolescents. While vitamin D deficiency has been studied in adult Raynaud’s patients and in various autoimmune conditions, pediatric data are limited. The finding that vitamin D deficiency correlates with symptom severity aligns with emerging research showing vitamin D’s role in immune regulation and blood vessel function. However, this exploratory study adds new evidence specific to the pediatric population.
The study has several important limitations. It examined only 61 patients from a single medical center, which limits how broadly the findings apply. The study was retrospective, meaning researchers relied on existing medical records rather than prospectively collecting data in a controlled way. There was no control group of children without Raynaud’s to compare vitamin D levels against. The follow-up period varied among patients, and not all vitamin D-deficient patients received supplementation, making it harder to draw firm conclusions about treatment effects. The study is exploratory and hypothesis-generating rather than hypothesis-testing, meaning it identifies patterns for future research but cannot prove cause-and-effect relationships.
The Bottom Line
Based on this exploratory research, doctors may consider checking vitamin D levels in children and adolescents with Raynaud’s phenomenon, particularly those with severe symptoms. If deficiency is found, vitamin D supplementation appears to be a reasonable intervention worth trying, as it showed promise in reducing symptom severity. However, these recommendations should be considered preliminary (low to moderate confidence level) pending larger, randomized controlled trials. Vitamin D supplementation is generally safe and inexpensive, making it a low-risk intervention to discuss with your child’s doctor.
Parents and doctors caring for children and teens with Raynaud’s phenomenon should pay attention to this research, especially if symptoms are severe or significantly affecting quality of life. Children with other autoimmune conditions may also benefit from vitamin D screening. This research is less relevant for children without Raynaud’s or those with very mild symptoms. Adults with Raynaud’s should consult their own doctors, as this study focused specifically on pediatric patients.
Based on the study data, patients who received vitamin D supplementation showed improvements in symptom severity scores during follow-up periods averaging 3 years. However, the timeline for individual improvement likely varies. Some patients may notice benefits within weeks to months, while others may require longer supplementation. Consistent vitamin D levels need to be maintained, so this is not a one-time treatment but an ongoing approach.
Frequently Asked Questions
Can vitamin D deficiency cause Raynaud’s phenomenon in children?
This study found that vitamin D deficiency is common in children with Raynaud’s and correlates with symptom severity, but it cannot prove that deficiency causes the condition. The connection appears real, but larger studies are needed to determine if correcting deficiency prevents or causes Raynaud’s.
Should my child with Raynaud’s get their vitamin D levels checked?
If your child has Raynaud’s, especially with severe symptoms affecting quality of life, discussing vitamin D screening with their doctor is reasonable. This exploratory research suggests it may be worthwhile, though it’s not yet standard practice for all children with Raynaud’s.
How much vitamin D should children with Raynaud’s take?
This study did not specify exact supplementation doses. Appropriate vitamin D dosing for children varies by age, baseline levels, and individual needs. Your child’s doctor should determine the right dose based on blood test results and clinical guidelines.
How long does it take for vitamin D supplements to improve Raynaud’s symptoms?
The study followed patients for an average of 3 years and found symptom improvement over time with supplementation. Individual timelines vary, but benefits may take weeks to months to become noticeable. Consistent supplementation is necessary to maintain vitamin D levels.
Is this study proof that vitamin D supplements will help my child’s Raynaud’s?
No, this exploratory study suggests a promising connection but cannot prove vitamin D supplements will help individual children. The study was small, conducted at one center, and the authors recommend larger randomized trials to confirm these findings before making it standard treatment.
Want to Apply This Research?
- Track your child’s Raynaud’s symptom severity using a simple 0-10 scale twice weekly, noting the number of episodes, duration, and which fingers are affected. Record vitamin D supplement doses and timing. Compare severity scores month-to-month to identify trends.
- If your child has been diagnosed with vitamin D deficiency and Raynaud’s, work with your doctor to establish a vitamin D supplementation routine. Use the app to set daily reminders for taking supplements and to log vitamin D levels from periodic blood tests. Track outdoor sun exposure time as a complementary source of vitamin D.
- Establish a baseline symptom severity score before starting vitamin D supplementation. Check vitamin D blood levels every 3 to 6 months initially, then annually once levels stabilize. Use the app to create a graph showing symptom severity over time alongside vitamin D supplementation dates to visualize any correlation between treatment and improvement.
This article summarizes exploratory research findings and should not be considered medical advice. Raynaud’s phenomenon in children requires proper medical evaluation and diagnosis by a qualified healthcare provider. Do not start, stop, or change any supplements or medications without consulting your child’s doctor. Vitamin D supplementation should only be undertaken under medical supervision with appropriate blood testing. This study is preliminary and larger trials are needed to confirm findings. Individual results may vary, and what works for one child may not work for another.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.